Protalix BioTherapeutics
PLX
#8648
Rank
NZ$0.13 B
Marketcap
$1.78
Share price
-4.35%
Change (1 day)
-38.32%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -NZ$21.45 M

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings (TTM) are -NZ$21.27 M. In 2023 the company made an earning of NZ$18.99 M an increase over its 2022 earnings that were of -NZ$19.19 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$21.45 M-212.87%
2023 NZ$18.99 M-199.05%
2022 -NZ$19.19 M-40.38%
2021 -NZ$32.18 M-732.31%
2020 NZ$5.08 M-130.53%
2019 -NZ$16.67 M189.85%
2018 -NZ$5.75 M-95.29%
2017 -NZ$0.13 B308.12%
2016 -NZ$29.93 M-32.37%
2015 -NZ$44.25 M10.11%
2014 -NZ$40.18 M-7.59%
2013 -NZ$43.48 M
2011 -NZ$50.35 M-19.39%
2010 -NZ$62.46 M20.87%
2009 -NZ$51.68 M32.26%
2008 -NZ$39.07 M-5.46%
2007 -NZ$41.33 M
2004 -NZ$0.27 M12.35%
2003 -NZ$0.24 M-11.1%
2002 -NZ$0.27 M-57.03%
2001 -NZ$0.63 M1.03%
2000 -NZ$0.62 M-53.22%
1999 -NZ$1.32 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.17 B 658.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.80 B-3,895.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$1.96 B 9,110.43%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.33 B-6,384.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel